Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × Pathologic Complete Response × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Completed 4 Active not recruiting 4 Recruiting 3 Withdrawn 1 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Carcinoma, Non-Small-Cell Lung 22 Neoplasms 11 Rectal Neoplasms 10 Lung Neoplasms 10 Leukemia, Myeloid, Acute 10 Colorectal Neoplasms 10 Nasopharyngeal Carcinoma 8 Stomach Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Small Cell Lung Carcinoma 7 Carcinoma, Hepatocellular 7 Ovarian Neoplasms 6 Non-Muscle Invasive Bladder Neoplasms 6 Glioblastoma 6 Esophageal Squamous Cell Carcinoma 6 Recurrence 5 Prostatic Neoplasms 5 Esophageal Neoplasms 5 Carcinoma, Renal Cell 5 Brain Neoplasms 5 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Colonic Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Lymphoma, Follicular 3 Endometrial Neoplasms 3

Interventions

tegafur-gimeracil-oteracil 1 Radiation 1 Oxaliplatin 1 Magnetic Resonance Imaging 1 Leucovorin 1 Irinotecan 1 Induction Chemotherapy 1 Folfox protocol 1 Fluorouracil 1 FOLFOXIRI protocol 1 Endoscopy 1 Colonoscopy 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡